retatrutide phase 2 trial results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a study: • Up to 24.2% mean weight loss at 48 weeks A new weight-loss drug called
Description
Scientific References Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial
Should I change how often I eat while taking retatrutide

Sanitize hands & injection site

Aetna cut coverage for Zepbound on July 1, 2025

For many people, the noise drops dramatically, sometimes for the first time in in their lives

However, beginners to resistance training may experience "newbie gains"simultaneous fat loss and muscle growtheven while taking GLP-1 medications and losing weight
